1Protocol for diagnosis and treatment of human infection with influenza A (H7N9) virus (Edition 2, 2013)Special Report65-672Focus on emerging infectious diseases and conquer influenza A (H7N9) virusWANG Yong-yi, LI Jun, ZHANG Ling-xiaSpecial Report68-683Preliminary analysis of the features of 102 cases of human infection with influenza A (H7N9) virus in ChinaHAN Ming-feng, RAN Xian-gui, ZHAO Feng-de, CHENG Guo-ling, SHEN Hui, WANG Rui-ruiSpecial Report68-70,814China's guideline on nosocomial infection prevention and control of viral hepatitis CSpecial Report71-755Recommendation on antiviral therapy for HBV/HCV-related hepatocellular carcinomaGuidance & Comments76-816Brief introduction to the key points of the 2011 AASLD's practice guideline on treatment of genotype 1 chronic hepatitis C virus infectionXU Xiao-yuan, FAN Xiao-hong, SHAO Cui-pingGuidance & Comments82-847Research progress of sofosbuvir and ABT-450, the newest direct-acting anti-HCV agentsZENG Qing-lei, LI Yuan-yuan, WANG Fu-shengGuidance & Comments85-88,928Recent advances in diagnosis, prevention and treatment of hepatitis EGuidance & Comments89-929Factors affecting HBV gene mutations in chronic HBV-infected patients receiving nucleos(t)ide analogue therapyZHAO Pan, DAI Jiu-zeng, LIU Fang-fang, YAO Zeng-tao, LI Le, XIN Shao-jie, XU Dong-pingOriginal Articles93-95,13010Identification of various entecavir-resistant HBV strains and analysis of the inhibitory efficacy of tenofovir disoproxilLI Yan-le, LIU Yan, XU Zhi-hui, WANG Xiao, CHEN Li, DAI Jiu-zeng, YAO Zeng-tao, JIANG Ling, ZHANG Lian-feng, XU Dong-pingOriginal Articles96-99,10711Determination of peripheral blood natural killer cell subsets in patients with chronic HCV infection and analysis of its clinical significanceZHANG Min, XU Xiang-sheng, QIN En-qiang, HU Jin-hua, TONG Jing-jing, DUAN Xue-zhangOriginal Articles100-10212Correlation between antiviral efficacy and serum levels of Th1/Th2 cytokines in patients with chronic hepatitis CGUO Dan-dan, ZHANG Yong-hong, MA Li-na, LIU Ya-li, LU Jun-feng, JIN Yi, HE Zhi-min, HUA Wei, ZHENG Yan-hong, CHEN Xin-yueOriginal Articles103-10713Combination therapy of Anluohuaxian capsule and adefovir dipivoxil for patients with hepatitis B-related compensated cirrhosisWANG Jian-guo, ZHANG Yun-huiClinical Researches108-11114Correlation between HBV serum markers and HBV DNA in patients with chronic hepatitis BSHEN Huan-jun, CHEN Jing-yin, ZHANG Zhong-wei, WEI Yao, JIA Li-hong, KANG Bi-bo, WANG Ping-zhongClinical Researches111-11415Interferon α-2b treatment for chronic hepatitis B complicated by type 2 diabetes mellitusKANG Xi, WANG FangClinical Researches115-11716Drug resistance of adefovir dipivoxilFAN Zhen-ping, JI Ying-jie, QIN Li, XU Dong-ping, ZHANG Hai-yan, SHI Xue-min, WANG Xue-qin, CAI Shao-ping, BU Xin, HE Wei-ping, ZHANG Wen-jinReviews119-12217Progress and clinical significance of HCV genotypingGAO Li, YANG Shao-minReviews122-12518Development of direct-acting antiviral agents against HCVSU Hai-binReviews126-130 